Literature DB >> 28451417

Proteus syndrome: A case report and review of the literature.

Minglin Ou1, Zhaojun Sun2, Peng Zhu2, Guoping Sun3, Yong Dai2.   

Abstract

Proteus syndrome is a rare complex syndrome involving clinical presentation with atypical skeletal growth. Only a limited number of cases with this syndrome have been reported in the literature to date. We herein report the case of a Chinese male patient with Proteus syndrome and review the clinical and molecular characteristics of this disease. The patient was a 34-year-old man with clinical manifestations suggestive of the Proteus syndrome, including mosaic distribution of the lesions, sporadic occurrence, progressive course, disproportionate overgrowth of the legs, epidermal nevi, lipomas, venous malformations and characteristic facial phenotype. Genetic mosaicism, such as mutations involving the phosphoinositide 3 kinase-AKT pathway in the affected tissues, may be important causes of Proteus syndrome. In the present case, samples from the affected tissues were collected from the patient and were further analyzed using whole-exome sequencing. However, no mutation of the genes reportedly associated with Proteus syndrome was identified in the affected tissues. Proteus syndrome is a complex mosaic disorder with a number of variable characteristics. Although activating AKT1 mutations have been found to be associated with this disorder, the molecular etiology remains to be fully elucidated and diagnostic criteria must be established in the clinical setting.

Entities:  

Keywords:  Proteus syndrome; diagnosis; whole-exome sequencing

Year:  2017        PMID: 28451417      PMCID: PMC5403503          DOI: 10.3892/mco.2017.1140

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  12 in total

1.  A newly recognized hamartomatous syndrome.

Authors:  M M Cohen; P W Hayden
Journal:  Birth Defects Orig Artic Ser       Date:  1979

Review 2.  Reassessment of the Proteus syndrome literature: application of diagnostic criteria to published cases.

Authors:  Joyce T Turner; M Michael Cohen; Leslie G Biesecker
Journal:  Am J Med Genet A       Date:  2004-10-01       Impact factor: 2.802

Review 3.  Proteus syndrome review: molecular, clinical, and pathologic features.

Authors:  M Michael Cohen
Journal:  Clin Genet       Date:  2013-10-23       Impact factor: 4.438

Review 4.  The challenges of Proteus syndrome: diagnosis and management.

Authors:  Leslie Biesecker
Journal:  Eur J Hum Genet       Date:  2006-08-02       Impact factor: 4.246

5.  A mosaic activating mutation in AKT1 associated with the Proteus syndrome.

Authors:  Marjorie J Lindhurst; Julie C Sapp; Jamie K Teer; Jennifer J Johnston; Erin M Finn; Kathryn Peters; Joyce Turner; Jennifer L Cannons; David Bick; Laurel Blakemore; Catherine Blumhorst; Knut Brockmann; Peter Calder; Natasha Cherman; Matthew A Deardorff; David B Everman; Gretchen Golas; Robert M Greenstein; B Maya Kato; Kim M Keppler-Noreuil; Sergei A Kuznetsov; Richard T Miyamoto; Kurt Newman; David Ng; Kevin O'Brien; Steven Rothenberg; Douglas J Schwartzentruber; Virender Singhal; Roberto Tirabosco; Joseph Upton; Shlomo Wientroub; Elaine H Zackai; Kimberly Hoag; Tracey Whitewood-Neal; Pamela G Robey; Pamela L Schwartzberg; Thomas N Darling; Laura L Tosi; James C Mullikin; Leslie G Biesecker
Journal:  N Engl J Med       Date:  2011-07-27       Impact factor: 91.245

6.  Histopathological features of Proteus syndrome.

Authors:  S E H Hoey; D Eastwood; F Monsell; L Kangesu; J I Harper; N J Sebire
Journal:  Clin Exp Dermatol       Date:  2008-01-16       Impact factor: 3.470

7.  The proteus syndrome. Partial gigantism of the hands and/or feet, nevi, hemihypertrophy, subcutaneous tumors, macrocephaly or other skull anomalies and possible accelerated growth and visceral affections.

Authors:  H R Wiedemann; G R Burgio; P Aldenhoff; J Kunze; H J Kaufmann; E Schirg
Journal:  Eur J Pediatr       Date:  1983-03       Impact factor: 3.183

8.  Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity.

Authors:  Frédéric Caux; Henri Plauchu; Frédéric Chibon; Laurence Faivre; Olivier Fain; Pierre Vabres; Françoise Bonnet; Zied Ben Selma; Liliane Laroche; Marion Gérard; Michel Longy
Journal:  Eur J Hum Genet       Date:  2007-03-28       Impact factor: 4.246

9.  Proteus syndrome: report of a case with recurrent abdominal lipomatosis.

Authors:  Isabel Furquim; Rachel Honjo; Ricardo Bae; Wagner Andrade; Maria Santos; Uenis Tannuri; Chong Kim
Journal:  J Pediatr Surg       Date:  2009-04       Impact factor: 2.545

10.  Proteus syndrome: Clinical diagnosis of a series of cases.

Authors:  Cresio Alves; Angelina X Acosta; Maria Betânia P Toralles
Journal:  Indian J Endocrinol Metab       Date:  2013-11
View more
  5 in total

1.  Variation in Akt protein kinases in human populations.

Authors:  Peter Rotwein
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-09-20       Impact factor: 3.619

2.  The Role of Interventional Pain Management in Proteus Syndrome: A Case Report.

Authors:  Ben Silverman; Gurtej Bajaj; Eric Liu; Adison Weseloh; Adrian Popescu
Journal:  Cureus       Date:  2022-05-01

3.  Proteus Syndrome: A Rare Case in An Adult Ward.

Authors:  Catarina Duarte Santos; Rita Lizardo Grácio; Tatiana Costa Pires; Miguel Gonzalez Santos; Rita J Rodrigues; Miriam Magalhães; Alcina Mota Ponte
Journal:  Eur J Case Rep Intern Med       Date:  2021-04-28

4.  Proteus Syndrome, a rare case with an unusual presentation: Case report.

Authors:  N Amer; J Al Helal; M Al Hajji; A Al Abduljabbar; M Al Arfaj; H Al Sadery; A Awadallah
Journal:  Int J Surg Case Rep       Date:  2020-06-13

5.  Validation of a computational phenotype for finding patients eligible for genetic testing for pathogenic PTEN variants across three centers.

Authors:  Cartik Kothari; Siddharth Srivastava; Youssef Kousa; Rima Izem; Marcin Gierdalski; Dongkyu Kim; Amy Good; Kira A Dies; Gregory Geisel; Hiroki Morizono; Vittorio Gallo; Scott L Pomeroy; Gwenn A Garden; Lisa Guay-Woodford; Mustafa Sahin; Paul Avillach
Journal:  J Neurodev Disord       Date:  2022-03-23       Impact factor: 4.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.